Outset Medical, Inc.
OM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $29,431 | $31,419 | $29,752 | $29,467 |
| % Growth | -6.3% | 5.6% | 1% | – |
| Cost of Goods Sold | $17,841 | $19,552 | $18,686 | $18,720 |
| Gross Profit | $11,590 | $11,867 | $11,066 | $10,747 |
| % Margin | 39.4% | 37.8% | 37.2% | 36.5% |
| R&D Expenses | $5,376 | $5,289 | $5,515 | $7,889 |
| G&A Expenses | $8,477 | $9,163 | $8,298 | $9,267 |
| SG&A Expenses | $22,027 | $23,443 | $21,950 | $24,718 |
| Sales & Mktg Exp. | $13,550 | $14,280 | $13,652 | $15,451 |
| Other Operating Expenses | -$343 | $0 | $0 | $0 |
| Operating Expenses | $27,060 | $28,732 | $27,465 | $32,607 |
| Operating Income | -$15,470 | -$16,865 | -$16,399 | -$21,860 |
| % Margin | -52.6% | -53.7% | -55.1% | -74.2% |
| Other Income/Exp. Net | -$1,621 | -$1,572 | -$9,269 | -$3,782 |
| Pre-Tax Income | -$17,434 | -$18,437 | -$25,668 | -$25,642 |
| Tax Expense | $404 | $104 | $115 | -$4 |
| Net Income | -$17,838 | -$18,541 | -$25,783 | -$25,638 |
| % Margin | -60.6% | -59% | -86.7% | -87% |
| EPS | -1 | -1.04 | -7.44 | -0.5 |
| % Growth | 3.8% | 86% | -1,388% | – |
| EPS Diluted | -1 | -1.04 | -7.44 | -0.5 |
| Weighted Avg Shares Out | 17,783 | 17,743 | 3,463 | 3,415 |
| Weighted Avg Shares Out Dil | 17,783 | 17,743 | 3,463 | 3,415 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,903 | $1,976 | $2,043 |
| Interest Expense | $3,476 | $3,475 | $3,560 | $5,825 |
| Depreciation & Amortization | $322 | $1,155 | $1,294 | $1,406 |
| EBITDA | -$13,636 | -$16,865 | -$20,814 | -$18,411 |
| % Margin | -46.3% | -53.7% | -70% | -62.5% |